Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

By afschroeder • March 9, 2026

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade E, Miller LG, Jacob JT, Satlin MJ, Krsak M, Huskins WC, Dhar S, Shelburne SA, Hill C, Alby K, Sadler JM, Hill BM, Greenwood-Quaintance KE, Schmidt-Malan SM, Patel R, Fowler VG Jr, Tamma PD, Kreiswirth BN, van Duin D; Antibacterial Resistance Leadership Group. Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections. Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093/cid/ciag160. Epub ahead of print. PMID: 41795867.

Tags: bacteremia, carbapenems, ceftriaxone resistance, E. coli, Harbor UCLA, Infectious Diseases, Publications, ST131

Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease

Naim MAAZ, Thomas F, Streja E, Davis RL, Kalantar-Zadeh K, Sumida K, Kovesdy CP. Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels[...]

Dynamic Assessment of Exercise Gas Exchange Efficiency by Breath-by-Breath Volumetric Capnography in Mild-Moderate COPD

James MD, McCleary J, Back GD, Alosta KA, Smyth RM, Vincent SG, Wang CY, Domnik NJ, Borghi-Silva A, Stringer W, Porszasz J, O'Donnell DE, Neder[...]

EcoRxChoice.com- an SIDP-funded calculator integrating environmental metrics with antimicrobial stewardship

Lee PS, Gordon H, Ferguson T, Dinh T, Vu M, Nguyen M, Hsiao C, Fong G. EcoRxChoice.com- an SIDP-funded calculator integrating environmental metrics with antimicrobial[...]